Avidity Biosciences Inc
NASDAQ:RNA

Watchlist Manager
Avidity Biosciences Inc Logo
Avidity Biosciences Inc
NASDAQ:RNA
Watchlist
Price: 72.15 USD -0.03%
Market Cap: 10.9B USD

Wall Street
Price Targets

RNA Price Targets Summary
Avidity Biosciences Inc

Wall Street analysts forecast RNA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RNA is 74.07 USD with a low forecast of 65.65 USD and a high forecast of 100.8 USD.

Lowest
Price Target
65.65 USD
9% Downside
Average
Price Target
74.07 USD
3% Upside
Highest
Price Target
100.8 USD
40% Upside
Avidity Biosciences Inc Competitors:
Price Targets
SPRB
Spruce Biosciences Inc
158% Upside
NTRA
Natera Inc
6% Upside
GBIO
Generation Bio Co
61% Upside
LGND
Ligand Pharmaceuticals Inc
31% Upside
CVAC
CureVac NV
7% Upside
2256
Abbisko Cayman Ltd
84% Upside

Revenue
Forecast

Revenue Estimate
Avidity Biosciences Inc

For the last 5 years the compound annual growth rate for Avidity Biosciences Inc's revenue is 36%. The projected CAGR for the next 4 years is 201%.

36%
Past Growth
201%
Estimated Growth
Estimates Accuracy
5%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Avidity Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
4%
Average Beat

Net Income
Forecast

Net Income Estimate
Avidity Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-66%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RNA's stock price target?
Price Target
74.07 USD

According to Wall Street analysts, the average 1-year price target for RNA is 74.07 USD with a low forecast of 65.65 USD and a high forecast of 100.8 USD.

What is Avidity Biosciences Inc's Revenue forecast?
Projected CAGR
201%

For the last 5 years the compound annual growth rate for Avidity Biosciences Inc's revenue is 36%. The projected CAGR for the next 4 years is 201%.

Back to Top